Patent US4614811A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4614811A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel organoplatinum(II) complexes and method for the preparation thereof

Assignee: Yissum Research Development Co of Hebrew University of Jerusalem
•
Filing: 1985-03-18
•
Granted: 1986-09-30
•
Expires: 2005-03-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Amino-substituted-malonato platinum(II) complexes represented by the gene formula L.sub.2 Pt.sup.II (OCO).sub.2 CH--NH.sub.2 wherein L and L 2 are monodentate and bidentate aliphatic amine ligands respectively. Typical examples of L and L 2 are: NH 3 , ethylendiamine, 1,2-diaminocyclohexane, ethylenimine, and cyclopropyl-, cyclobutyl-, cyclopentyl-, cyclohexyl-, isopropyl-, n-propyl-amine. The compounds are characterized by high antitumor activity in mice, chemical stability and solubility in aqueous fluids for i.v. administration. The invention provides also a preferred method for their preparation.

Inventors

  • 👤 Ottavio Gandolfi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 08:35
CPC Classifications
C; C07; C07F; C07F15/00; C07F15/0006; C07F15/0086; C07F15/0093

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 181 words
Amino-substituted malonato platinum complexes having the general formula: L.sub.2 Pt.sup.II (OCO).sub.2 CH--NH.sub.2 wherein: L is a monodentate aliphatic amine ligand of the type HNRR 1 or an amino acid, wherein, when R=H, R 1 is selected from the group consisting of H, hydroxy, lower alkyl, cycloalkyl, hydroxy lower alkyl, and lower alkoxy; R and R 1 can also be combined to form an imine group; L 2 is a bidentate aliphatic amine ligand of the type HNR 2 --CHR 3 --(CR 4 R 5 ) n --CHR 6 --NHR 7 , wherein n=0 or 1, and R 2 , R 3 , R 4 , R 5 , R 6 , R 7 are the same or different substituents and are selected from the group consisting of H, hydroxy, lower alkyl, lower alkoxy cycloalkyl; when n=0, R 3 and R 6 can be combined to form a cycloalkyl group; when n=1, R 3 can be combined with R 4 , or R 4 and R 5 can be combined with the carbon atom, to form in each case a cycloalkyl group.
Claim 2
Dependent Claim 181 words
Amino-substituted malonato platinum complexes having the general formula: L.sub.2 Pt.sup.II (OCO).sub.2 CH--NH.sub.2 wherein: L is a monodentate aliphatic amine ligand of the type HNRR 1 or an amino acid, wherein, when R=H, R 1 is selected from the group consisting of H, hydroxy, lower alkyl, cycloalkyl, hydroxy lower alkyl, and lower alkoxy; R and R 1 can also be combined to form an imine group; L 2 is a bidentate aliphatic amine ligand of the type HNR 2 --CHR 3 --(CR 4 R 5 ) n --CHR 6 --NHR 7 , wherein n=0 or 1, and R 2 , R 3 , R 4 , R 5 , R 6 , R 7 are the same or different substituents and are selected from the group consisting of H, hydroxy, lower alkyl, lower alkoxy cycloalkyl; when n=0, R 3 and R 6 can be combined to form a cycloalkyl group; when n=1, R 3 can be combined with R 4 , or R 4 and R 5 can be combined with the carbon atom, to form in each case a cycloalkyl group.
Claim 3
Dependent Claim 14 words
Aminomalonate(diamine)platinum(II), (AM--DP) of the formula of claim 1, wherein L is NH 3 .
Claim 4
Dependent Claim 13 words
Aminomalonate(ethylendiamine)platinum(II), (AM--EP), of the formula of claim 1, wherein L 2 is ethylendiamine.
Claim 5
Dependent Claim 13 words
Aminomalonate(1,2-diaminocyclohexane)platinum(II), (AM--DACHP), of the formula of claim 1, wherein L 2 is 1,2-diaminocyclohexane.
Claim 6
Dependent Claim 12 words
Aminomalonate(diethylenimine)platinum(II), (AM--AZP), of the formula of claim 1, wherein L is ethylenimine.
Claim 7
Dependent Claim 12 words
Aminomalonate(dicyclopropylamine)platinum(II), (AM--CPRP), of the formula of claim 1, wherein L is cyclopropylamine.
Claim 8
Dependent Claim 12 words
Aminomalonate(dicyclobutylamine)platinum(II), (AM--CBP), of the formula of claim 1, wherein L is cyclobutylamine.
Claim 9
Dependent Claim 12 words
Aminomalonate(dicyclopentylamine)platinum(II), (AM--CPP), of the formula of claim 1, wherein L is cyclopentylamine.
Claim 10
Dependent Claim 12 words
Aminomalonate(dicyclohexylamine)platinum(II), (AM--CHP), of the formula of claim 1, wherein L is cyclohexylamine.
Claim 11
Dependent Claim 12 words
Aminomalonate(diisopropylamine)platinum(II), (AM--IPA), of the formula of claim 1, wherein L is isopropylamine.
Claim 12
Dependent Claim 12 words
Aminomalonate(din-propylamine)platinum(II), (AM--NPA), of the formula of claim 1, wherein L is n-propylamine.
Claim 13
Independent Claim 239 words
A method for the preparation of amino-substituted malonato platinum complexes having the general formula: L.sub.2 Pt.sup.II (OCO).sub.2 CH--NH.sub.2 wherein: L is a monodentate aliphatic amine ligand of the type HNRR 1 or an aminoacid, wherein, when R=H, R 1 is selected from the group consisting of H, hydroxy, lower alkyl, cycloalkyl, hydroxy lower alkyl, and lower alkoxy; R and R 1 can also be combined to form an imine group; L 2 is a bidentate aliphatic amine ligand of the type HNR 2 --CHR 3 --(CR 4 R 5 ) n --CHR 6 --NHR 7 , wherein n=0 or 1, and R 2 , R 3 , R 4 , R 5 , R 6 , R 7 are the same or different substituents and are selected from the group consisting of H, hydroxy, lower alkyl, lower alkoxy, cycloalkyl; when n=0, R 3 and R 6 can be combined to form a cycloalkyl group; when n=1, R 3 can be combined with R 4 , or R 4 and R 5 can be combined with the carbon atom, to form in each case a cycloalkyl group; said method comprising reacting the barium salt of aminomalonic acid with a platinum(II) sulfate intermediate having the general formula L 2 PtSO 4 , wherein L and L 2 are defined as in the general formula above, to form the complex of the formula L 2 Pt II (OCO) 2 CH--NH 2 .
Claim 14
Independent Claim 239 words
A method for the preparation of amino-substituted malonato platinum complexes having the general formula: L.sub.2 Pt.sup.II (OCO).sub.2 CH--NH.sub.2 wherein: L is a monodentate aliphatic amine ligand of the type HNRR 1 or an aminoacid, wherein, when R=H, R 1 is selected from the group consisting of H, hydroxy, lower alkyl, cycloalkyl, hydroxy lower alkyl, and lower alkoxy; R and R 1 can also be combined to form an imine group; L 2 is a bidentate aliphatic amine ligand of the type HNR 2 --CHR 3 --(CR 4 R 5 ) n --CHR 6 --NHR 7 , wherein n=0 or 1, and R 2 , R 3 , R 4 , R 5 , R 6 , R 7 are the same or different substituents and are selected from the group consisting of H, hydroxy, lower alkyl, lower alkoxy, cycloalkyl; when n=0, R 3 and R 6 can be combined to form a cycloalkyl group; when n=1, R 3 can be combined with R 4 , or R 4 and R 5 can be combined with the carbon atom, to form in each case a cycloalkyl group; said method comprising reacting the barium salt of aminomalonic acid with a platinum(II) sulfate intermediate having the general formula L 2 PtSO 4 , wherein L and L 2 are defined as in the general formula above, to form the complex of the formula L 2 Pt II (OCO) 2 CH--NH 2 .

References Cited (Backward Citations)

US4140707A Cited
US4140707B1 Cited
US4115418A Cited
US4169846A Cited
US4203912A Cited
US4225529A Cited
US4230631A Cited
US4255347A Cited
US4359425A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-09-29 1990-03-31 1990-09-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-09-29 1994-03-31 1994-09-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-09-29 1998-03-31 1998-09-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag